67 related articles for article (PubMed ID: 9536559)
1. Postmenopausal HRT--a role for a safe antioestrogen.
Jackson I; Steinberg M; Orton TC
Int J Clin Pract; 1998; 52(1):5-6. PubMed ID: 9536559
[No Abstract] [Full Text] [Related]
2. Postmenopausal HRT--a role for a safe antioestrogen.
Williams GM
Int J Clin Pract; 1998; 52(1):5. PubMed ID: 9536558
[No Abstract] [Full Text] [Related]
3. MR appearance of endometrial carcinoma and mucinous cystadenoma in a postmenopausal patient treated with tamoxifen for breast cancer.
Joja I; Asakawa T; Ando Y; Shiraiwa M; Shibutani O; Akaki S; Kuroda M; Mizutani Y; Kudo T; Hiraki Y
Radiat Med; 1998; 16(4):315-9. PubMed ID: 9814431
[TBL] [Abstract][Full Text] [Related]
4. [Tamoxifen and endometrial cancer].
Salamanca-Gómez F
Gac Med Mex; 2006; 142(2):171-2. PubMed ID: 16711554
[No Abstract] [Full Text] [Related]
5. Significance of secondary ultrasonographic endometrial thickening in postmenopausal tamoxifen-treated women.
Timmerman D; Neven P; Deprest J; Konstantinović ML; Vergote I
Cancer; 2003 Jul; 98(2):431-2; author reply 432-3. PubMed ID: 12872366
[No Abstract] [Full Text] [Related]
6. Endometrial carcinoma and tamoxifen: clearing up a controversy.
Andersson M; Storm HH; Mouridsen HT
Clin Cancer Res; 1996 Jan; 2(1):223-4. PubMed ID: 9816110
[No Abstract] [Full Text] [Related]
7. Massive endometrial polyp after tamoxifen therapy.
Divers MJ
Br J Clin Pract; 1995; 49(5):275-6. PubMed ID: 7492471
[No Abstract] [Full Text] [Related]
8. Endometrial carcinoma can develop in patients on tamoxifen therapy.
Omar SZ; Sivanesaratnam V
Med J Malaysia; 1999 Jun; 54(2):280-2. PubMed ID: 10972045
[No Abstract] [Full Text] [Related]
9. Tamoxifen ruling in California.
Mack T
Science; 1995 Nov; 270(5239):1102-3. PubMed ID: 7502022
[No Abstract] [Full Text] [Related]
10. Endometrial polyps: a comparison study of patients receiving tamoxifen with two control groups.
Schlesinger C; Kamoi S; Ascher SM; Kendell M; Lage JM; Silverberg SG
Int J Gynecol Pathol; 1998 Oct; 17(4):302-11. PubMed ID: 9785130
[TBL] [Abstract][Full Text] [Related]
11. Endometrial polyps in pre-and postmenopausal women: factors associated with malignancy.
Cohen I
Maturitas; 2008 Jan; 59(1):99-100. PubMed ID: 18162338
[No Abstract] [Full Text] [Related]
12. Tamoxifen and endometrial neoplasia.
Barakat RR
Clin Obstet Gynecol; 1996 Sep; 39(3):629-40. PubMed ID: 8862888
[No Abstract] [Full Text] [Related]
13. Endometrial cancers from tamoxifen are not more aggressive.
Ziegler J
J Natl Cancer Inst; 1996 Aug; 88(16):1101. PubMed ID: 8757186
[No Abstract] [Full Text] [Related]
14. Breast cancer chemoprevention: risk-benefit effects of the antioestrogen tamoxifen.
Brown K
Expert Opin Drug Saf; 2002 Sep; 1(3):253-67. PubMed ID: 12904141
[TBL] [Abstract][Full Text] [Related]
15. Malignant endometrial polyps in postmenopausal breast cancer tamoxifen-treated patients.
Cohen I; Bernheim J; Azaria R; Tepper R; Sharony R; Beyth Y
Gynecol Oncol; 1999 Oct; 75(1):136-41. PubMed ID: 10502440
[TBL] [Abstract][Full Text] [Related]
16. Detection of endometrial cancer in asymptomatic postmenopausal breast cancer patient treated with tamoxifen: a case report.
Sinawat S; Chiyabutra T; Kleabkaew P
J Med Assoc Thai; 2001 Jul; 84(7):1033-6. PubMed ID: 11759963
[TBL] [Abstract][Full Text] [Related]
17. [The effects of tamoxifen on the female genital tract].
Mourits MJ; van der Zee AG; Willemse PH; Hollema H; de Vries EG
Ned Tijdschr Geneeskd; 2003 Nov; 147(47):2315-20. PubMed ID: 14669536
[TBL] [Abstract][Full Text] [Related]
18. The effect of clodronate and antioestrogens on bone loss associated with oestrogen withdrawal in postmenopausal women with breast cancer.
Saarto T; Vehmanen L; Elomaa I; Välimäki M; Mäkelä P; Blomqvist C
Br J Cancer; 2001 Apr; 84(8):1047-51. PubMed ID: 11308252
[TBL] [Abstract][Full Text] [Related]
19. Tamoxifen in cancer therapy: minireview.
Novotny L; Rauko P; Vachálková A; Peterson-Biggs M
Neoplasma; 2000; 47(1):3-7. PubMed ID: 10870680
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant tamoxifen versus tamoxifen plus CMF in the treatment of early breast cancer in Greece. Fifteen-year results of a randomised prospective trial and the potential risks of the antioestrogen.
Vorgias G; Koukouras D; Tzoracoeleftherakis E; Paleogianni V; Androulakis J
Anticancer Res; 2000; 20(5C):3849-54. PubMed ID: 11268466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
